Why the study?
Does the Factor Xa inhibitor rTAP delay thrombosis and reduce thrombus mass compared to heparin or saline in a canine coronary injury model?
Does the Factor Xa inhibitor rTAP delay thrombosis and reduce thrombus mass compared to heparin or saline in a canine coronary injury model?
In a canine model of coronary arterial thrombosis, the Factor Xa inhibitor rTAP demonstrated superior antithrombotic efficacy compared to heparin, significantly delaying occlusion and reducing thrombus mass.
Answers are grounded in this paper and cite their sources.
rTAP merits further preclinical and early clinical evaluation; leaves open translation to human coronary thrombosis prevention.
The antithrombotic efficacies of the coagulation factor Xa inhibitor recombinant tick anticoagulant peptide (rTAP) and heparin were compared in a canine model of left circumflex (LCX) coronary artery electrolytic lesion. Intravenous infusions of saline (controls), rTAP (50 micrograms/kg/min continuous infusion) or heparin (200 U/kg bolus followed by 2 U/kg/min continuous infusion) were started 60 min prior to the initiation of LCX coronary artery electrolytic injury (150 microA continuous anodal current). All 6/6 saline-treated control animals developed occlusive thrombi at 49.8 +/- 13.6 min after the initiation of vessel injury, and possessed a residual thrombus mass of 20.7 +/- 3.3 mg. In the rTAP treatment group, 4/6 preparations developed occlusive thrombi, but with times to thrombosis delayed significantly compared to both the saline control as well as to the heparin treatment group (202.7 +/- 28.9 min; p < 0.01 to both saline and heparin groups). The remaining 2 rTAP-treated preparations remained patent despite the continued electrical stimulation of the coronary vessel for 5 h. Residual thrombus mass in the rTAP treatment group was reduced markedly compared to the saline control group (4.4 +/- 1.0 mg; p < 0.01). Heparin infusion resulted in a modest but statistically insignificant delay in occlusive LCX coronary artery thrombosis compared to saline controls, with all 6/6 heparin-treated preparations occluding at 79.7 +/- 16.5 min after the initiation of vessel injury. Residual thrombus mass in heparin-treated animals, however, was reduced compared to saline controls (9.4 +/- 1.4 mg; p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Lynch et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: